What is the first-line medication for acute delirium and its recommended dosing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Best Medication for Delirium

Haloperidol 0.5-1 mg orally or subcutaneously is the first-line medication for acute delirium when pharmacological treatment is necessary, but only after addressing reversible causes and attempting non-pharmacological interventions first. 1

Critical Context: When to Use Medications

Do NOT routinely use antipsychotics for delirium unless:

  • The patient has severe agitation threatening substantial harm to self or others
  • The patient has distressing perceptual disturbances (hallucinations, delusions)
  • Non-pharmacological interventions have failed or are not possible 2, 3

Strongly avoid pharmacological treatment for:

  • Hypoactive delirium without agitation 2
  • Mild-to-moderate delirium 3

First-Line Approach: Address Reversible Causes

Before prescribing any medication:

  • Treat hypoxia, urinary retention, constipation
  • Ensure adequate lighting and orientation
  • Review and discontinue deliriogenic medications (anticholinergics, benzodiazepines)
  • Optimize pain control 1

Medication Algorithm for Delirium

For Hyperactive Delirium (Able to Swallow)

Haloperidol:

  • Start: 0.5-1 mg orally at night and every 2 hours as needed
  • Elderly patients: Start at 0.5 mg
  • Titrate in 0.5-1 mg increments
  • Maximum: 10 mg daily (5 mg daily in elderly)
  • If severely distressed or immediate danger: Start with 1.5-3 mg 1

Alternative second-generation antipsychotics (if haloperidol contraindicated or ineffective):

  • Olanzapine: 2.5-5 mg orally or subcutaneously (may offer benefit) 3
  • Quetiapine: 25 mg orally every 12 hours (more sedating, oral only) 3
  • Risperidone: 0.5 mg orally (higher EPSE risk at doses >6 mg/day) 3

For Hyperactive Delirium (Unable to Swallow)

Levomepromazine (Methotrimeprazine):

  • Start: 12.5-25 mg subcutaneously (6.25-12.5 mg in elderly)
  • Then hourly as required
  • Maintenance: 50-200 mg subcutaneous infusion over 24 hours 1

Haloperidol subcutaneous:

  • Same doses as oral route
  • Can use subcutaneous infusion: 2.5-10 mg over 24 hours 1

When to Add Benzodiazepines

DO NOT use benzodiazepines as first-line treatment except for:

  • Alcohol withdrawal delirium
  • Benzodiazepine withdrawal delirium 2, 3

Add benzodiazepine to antipsychotic only if:

  • Patient remains severely agitated despite antipsychotic
  • Crisis situation with severe distress and safety risk 1, 3

Dosing when combined with antipsychotic:

  • Lorazepam: 0.5-1 mg subcutaneously/IV every 1 hour PRN (reduce to 0.25-0.5 mg in elderly/frail)
  • Midazolam: 2.5 mg subcutaneously/IV every 1 hour PRN (reduce to 0.5-1 mg in elderly/frail) 3

Critical Warnings

Haloperidol contraindications:

  • Parkinson's disease (absolute)
  • Dementia with Lewy bodies (absolute)
  • QTc prolongation risk—obtain ECG if giving IV 3

Evidence limitations: Recent high-quality evidence shows haloperidol and risperidone do NOT reduce delirium duration or severity in mild-to-moderate delirium and may worsen symptoms 3, 4. The 2018 Critical Care Medicine guidelines suggest NOT routinely using haloperidol or atypical antipsychotics for delirium treatment 4.

The paradox: Despite limited evidence for efficacy in reducing delirium duration or mortality, haloperidol remains guideline-recommended for short-term symptom management when patients are severely distressed or dangerous, at the lowest effective dose for the shortest duration 1, 2, 3, 1.

Daily Reassessment

  • Evaluate need for continued medication daily with in-person examination
  • Start medications PRN (as needed) basis
  • Convert to scheduled dosing only if symptoms persist
  • Discontinue as soon as safely possible 2, 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.